PHENYTOIN BUPROPION INTERACTION - EFFECT ON PLASMA PHENYTOIN CONCENTRATION IN THE RAT

被引:10
作者
TEKLE, A
ALKHAMIS, KI
机构
[1] Department of Clinical Pharmacy, College of Pharmacy, King Saud University
关键词
D O I
10.1111/j.2042-7158.1990.tb07025.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abstract— The effect of coadministration of bupropion (50 mg kg−1, p.o.) on the disposition profile of phenytoin has been studied in the rat. Plasma phenytoin concentration was measured serially for 10 h by HPLC. Bupropion had little or no effect on the pharmacokinetic parameters of an acutely administered dose of phenytoin. Following multiple doses of phenytoin however (i.e. steady state) the coadministration of bupropion resulted in significant increases in the elimination half‐life (t 1/2), the area under the plasma concentration‐time curve (AUC) and the time to maximum plasma concentration (tmax). Allowing for the limitations of single dose studies, these results point to a possible pharmacokinetic interaction between bupropion and phenytoin—the clinical significance of which needs to be assessed. 1990 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:799 / 801
页数:3
相关论文
共 11 条
[1]   STEADY-STATE PLASMA NORTRIPTYLINE CONCENTRATIONS IN EPILEPTIC PATIENTS [J].
BRAITHWAITE, RA ;
FLANAGAN, RJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (05) :469-471
[2]   PHARMACOKINETICS OF BUPROPION, A NOVEL ANTI-DEPRESSANT AGENT, FOLLOWING ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS [J].
FINDLAY, JWA ;
FLEET, JV ;
SMITH, PG ;
BUTZ, RF ;
HINTON, ML ;
BLUM, MR ;
SCHROEDER, DH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :127-135
[3]  
GOODMAN LS, 1985, PHARMACOL BASIS THER, P453
[4]  
GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135
[5]  
KUTT H, 1972, ANTIEPILEPTIC DRUGS, P169
[6]  
PERRUCA E, 1978, PHARMACOL THERAPEUT, V2, P285
[7]  
PERRUCA E, 1977, BR J CLIN PHARM, V4, P485
[8]  
PERRUCA E, 1982, CLIN PHARMACOKINET, V7, P57
[9]  
POND SM, 1975, CLIN PHARMACOL THER, V18, P191
[10]  
RAFTERY H, 1979, J IRISH MED ASSOC, V72, P399